4//SEC Filing
Campbell Chad Thomas 4
Accession 0001140361-24-035598
CIK 0001275187other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:48 PM ET
Size
9.0 KB
Accession
0001140361-24-035598
Insider Transaction Report
Form 4
Campbell Chad Thomas
SVP/GM, Vascular Access
Transactions
- Exercise/Conversion
Common Stock
2024-07-17+6,600→ 70,187 total - Exercise/Conversion
Performance Right
2024-07-17+8,777→ 0 total→ Common Stock (8,777 underlying) - Tax Payment
Common Stock
2024-07-17$7.40/sh−2,379$17,605→ 67,808 total
Footnotes (3)
- [F1]This acquisition of 6,600 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021.
- [F2]The exempt disposition of 2,379 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021.
- [F3]On July 21, 2021, the reporting person received a target grant of 8,777 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,600 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001706852
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 9:48 PM ET
- Size
- 9.0 KB